Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PTrana Meditama Metropolitan Tbk's annualized ROCE % for the quarter that ended in Mar. 2026 was 1.68%.
PTrana Meditama Metropolitan Tbk (ISX:SAME) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
PTrana Meditama Metropolitan Tbk ROCE % Related Terms
PTrana Meditama Metropolitan Tbk ROCE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
(1) Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PTrana Meditama Metropolitan Tbk (ISX:SAME) has a ROCE % of 1.68% as of Mar. 2026.
Is PTrana Meditama Metropolitan Tbk's ROCE % too high?
PTrana Meditama Metropolitan Tbk's current ROCE % is 1.68%. The Healthcare Providers & Services industry median ROCE % is 6.37. PTrana Meditama Metropolitan Tbk's value of 1.68% is 73.6% below this industry median. Overall, PTrana Meditama Metropolitan Tbk has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PTrana Meditama Metropolitan Tbk's ROCE % compare to HCA and THC?
PTrana Meditama Metropolitan Tbk's ROCE % of 1.68% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.37. PTrana Meditama Metropolitan Tbk's value of 1.68% is 73.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.37, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PTrana Meditama Metropolitan Tbk's current ROCE % of 1.68% is 73.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PTrana Meditama Metropolitan Tbk's current ROCE % is 1.68%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PTrana Meditama Metropolitan Tbk stock overvalued right now?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk (ISX:SAME) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp355.08, compared to a current price of Rp306.00 — trading 13.8% below its estimated fair value. The current ROCE % is 1.68% and 73.6% below the Healthcare Providers & Services industry median of 6.37. PTrana Meditama Metropolitan Tbk's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For PTrana Meditama Metropolitan Tbk (ISX:SAME), the current ROCE % is 1.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PTrana Meditama Metropolitan Tbk (ISX:SAME) Overvalued in 2026?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk stock appears to be undervalued.
The current stock price of Rp306.00 is trading 13.8% below its estimated GF Value™ of Rp355.08.
GuruFocus considers PTrana Meditama Metropolitan Tbk to be Modestly Undervalued.
Key valuation signals for ISX:SAME:
ROCE %: 1.68%
GF Value™: Rp355.08 vs. price of Rp306.00 (13.8% below fair value)
Industry Position: 73.6% below the Healthcare Providers & Services median
No single metric tells the full story. See the ISX:SAME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PTrana Meditama Metropolitan Tbk Business Description
PT Sarana Meditama Metropolitan Tbk is engaged in managing hospitals. Its hospitals are operated under the brand name Omni Hospital. The company manages and evaluates its business based on its geographic location consisting of Omni Pulomas, Omni Alam Sutera, Omni Cikarang, OMNI Pekayon, and others. It operates in Banten, DKI Jakarta, and West Java.
79GF Score
Get the complete analysis for ISX:SAME
ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SAME has been successfully added to your 
